F-18 Florbetazine

N/A

Report date: 2025/11/26 17:11:20

NME

Base Information

Drug NameF-18 Florbetazine

Drug Alias Name氟[18F]贝他嗪

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive diagnostic agent +[5]

Mechanisms of ActionRadionuclide imaging enhancersPositron-emission tomography enhancersBeta amyloid A4 protein binders

TargetsBeta amyloid A4 protein

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaPhase 3 Clinical

Originator CompaniesHta Co Ltd

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHta Co Ltd

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A